(linked to RHCZ12294)A SU011248 Expanded Access Protocol for Systematic Therapy of Patients with Metastatic Renal Cell Carcinoma who are Eligible for Participation in Other SU011248 Protocols and may Derive Benefit from Treatment with SU...
UHB NHS TRUST
1/07/06 → 31/12/14
BC2001: 2X2 Factorial Randomised Phase III Study Comparing Standard Versus Reduced Volume Radiotherapy With and Without Synchronous Chemotherapy in Muscle Invasive Bladder Cancer Research
Cancer Research UK
1/02/06 → 31/01/09
A Phase II, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Centre Study To Assess the Activity Of Once-Daily Orally Administered ZD4054 15MG and 10MG Doses On Bone Metastases In Pain-Free Or Mildly Systematic Patients..
UHB NHS TRUST
1/01/05 → 31/12/07
A Randomised Phase II Feasibility Study of Docetaxel plus Prednisolone vs Docetaxel plus Prednisolone plus Zoledronic acid vs docetaxel plus Prednisolone plus Strontium-89 vs Docetaxel plus prednisolone plus Zoledronic acid plus Strontium-8
AVENTIS PHARMA LTD, NOVARTIS PHARMACEUTICALS UK LTD
1/12/04 → 31/07/14
Prospective, Randomised Phase III Trial Of I.V. Vinflunine Plus Best Supportive Care As Second Line Therapy Versus Best Supportive Care After A Platimum-Containing Regimen, In Patients With Advanced Transitional Cell Carcinoma Of ...
INSTITUT DE RECHERCHE PIERRE FABRE
1/02/04 → 31/07/09